Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 5,444 shares at $131.87 ($725K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($725k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $129.92 | 105 | $14K | 1.9% |
| 2 | $130.79 | 219 | $29K | 3.9% |
| 3 | $131.87 | 539 | $71K | 9.8% |
| 4 | $131.87 | 539 | $71K | 9.8% |
| 5 | $132.71 | 921 | $122K | 16.9% |
| 6 | $132.71 | 921 |
| $122K |
| 16.9% |
| 7 | $133.67 | 567 | $76K | 10.5% |
| 8 | $133.67 | 567 | $76K | 10.5% |
| 9 | $134.66 | 152 | $20K | 2.8% |
| 10 | $135.97 | 457 | $62K | 8.6% |
| 11 | $135.97 | 457 | $62K | 8.6% |
| Total | $133.21 avg | 5,444 | $725K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |